Liposomes formed by a bilayer membrane of phospholipid are useful drug carriers that can contain or entrap various drugs. They are biodegradable and have low toxicity because they consist of natural components of biomembranes such as phospholipids and cholesterol. As they can be modified with various kinds of ligand such as immunoglobulin, 1) protein 2) or sugar residues, 3, 4) they can be used for drug targeting to specific sites and enhance the therapeutic effects by increasing drug association. We previously reported that drugs entrapped in liposomes modified with soybean-derived sterylglucoside (SG, SG-liposomes) accumulated in the liver, especially in hepatocytes, when administered to mice. 5, 6) Recognition of glucose moieties in liver cells was reported in previous studies, in which glucosylated albumin with a positively charged spacer in proximity to the sugar residue showed better effective uptake by isolated rat hepatocytes 7) and hepatocytes in mice 8) via asialoglycoprotein receptor (ASGP-R), which recognizes galactose residues. We also reported that both SG and b-sitosterol glucoside (Sit-G), a major component of SG, are effective penetration enhancers of drugs across mucosal membranes and the enhancement effect of Sit-G is higher than that of SG. 9, 10) Bile salt and glycyrrhizin are known to act as penetration enhancers in the intestinal, 11) nasal 12, 13) and transdermal 14) absorption of drugs, and also as ligands for drug delivery to the liver by their specific affinities to hepatocytes. 15, 16) Thus the penetration-enhancing effect of free SG or Sit-G on hepatocytes cannot be neglected, because they might be released by the degradation of SG-liposomes in the blood circulation or by Kupffer cells after i.v. injection. Therefore, we examined whether the accumulation of drug entrapped in SG-liposomes in the liver can be interpreted as indicating that SG is a liver-targeting ligand due to recognition by ASGP-R and Sit-G works as a penetration enhancer close to the hepatocyte.
In this study, we investigated the association of SG-liposomes using asialofetuin (AF) as a competitor in terms of ASGP-R recognition, the affinity of free Sit-G using a resonant mirror optical biosensor (IAsys), and the penetrationenhancing effect of Sit-G measuring the degree of association of FITC-dextran 4400 (FD-4) with the human hepatoma cell line HepG2.
MATERIALS AND METHODS
Materials Dipalmitoylphosphatidylcholine (DPPC) was purchased from NOF (Tokyo, Japan). Cholesterol (Ch), AF, FD-4, Hank's balanced salt solution (HBSS) and dimethyl sulfoxide (DMSO) were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.). SG was supplied by Ryukakusan Co. (Tokyo, Japan). SG is a mixture of steryl b-D-glucosides consisting of b-sitosterol (Sit-G, 49.9%), campesterol (29.1%), stigmasterol (13.8%) and brassicasterol (7.2%), and the chemical structures are shown in Fig. 1 Preparation of Liposomes The liposomes used in the present study were prepared from DPPC, Ch (DPPC : Chϭ 6 : 4, molar ratio, non-SG-liposomes) and SG (DPPC : Ch : SGϭ6 : 3 : 1, molar ratio, SG-liposomes) by the reversephase evaporation vesicle (REV) method as reported previously.
6) DiI, a lipophilic fluorescent marker, was added (0.4 mol%) to lipid mixtures to determine the behavior of the liposomal membrane. Liposomes were extruded through a polycarbonate membrane (0.2 mm pore size, Nuclepore, U.S.A.). The mean diameters of SG-and non-SG-liposomes labeled with DiI were 227.4 and 208.3 nm, respectively, determined using a dynamic laser light scattering instrument (Model ELS-800, Ostuka Electronics Co., Ltd., Japan). All of the DiI added was entrapped in liposomes as determined by gel filtration. Phospholipid concentration was determined by enzymatic assays (Phospholipid B Test Wako, Wako Pure Chemical Industries Ltd., Osaka, Japan), and liposome concentration was represented by DPPC concentration.
Determination of Cell-Associated SG-Liposomes The binding experiments were carried out at 4°C, and cell association experiments were performed at 37°C in 1 ml of serumfree RPMI 1640 medium containing 100 mM of each liposome as DPPC. To evaluate the involvement of ASGP-R, AF was added to medium at 1 mg/ml. More than 99% of the cells were viable at the end of the incubation periods as determined by the Trypan blue exclusion test. Incubation was terminated by washing the plates three times with ice-cold PBS. The washed cells were lysed in PBS containing 0.2% Triton X-100. The fluorescence intensity of DiI was assayed using a fluorophotometer (Hitachi F-4010, Tokyo, Japan) with excitation and emission wavelengths of 550 and 570 nm, respectively. The cell protein was measured using a bicinchonic acid (BCA) protein assay kit (Pierce Chemical Co., Rockford, IL, U.S.A.). The results are presented as associated amount of liposomes (DPPC) per mg of cellular protein, calculated from the fluorescence intensity of DiI.
IAsys Measurements Experiments were performed using an IAsys, resonant mirror optical biosensor (Affinity Sensors, Cambridge, U.K.). Sit-G was immobilized on hydrophobic cuvette surfaces according to the manufacturer's instructions. A known concentration of HepG2 or HeLa cells was cumulatively added to the cuvette, and changes in resonant angle were monitored at 0.3-s intervals for approximately 22 min at 22°C. Determination of Cellular Associated FD-4 by Sit-G Sit-G or oleic acid was dissolved into DMSO, and this solution was added to the 5 mg/ml FD-4 solution of HBSS to a final DMSO concentration of 1%. HepG2 cells plated in 12-well tissue culture plates were incubated with FD-4 solution containing various concentrations of Sit-G for the indicated times at 4°C or 37°C. After incubation, cells were washed three times with ice-cold HBSS and dissolved in PBS containing 0.2% Triton X-100. Associated amount of FD-4 was measured using a fluorophotometer with excitation and emission wavelengths of 490 and 520 nm, respectively. That of Sit-G was determined by HPLC. The HPLC system consisted of a Shimadzu SCL-10A system controller, SIL-10A autoinjector, LC-10AS liquid chromatograph, SPD-6A UV spectrophotometric detector and C-R6A chromatopac. The cell lysate was dried under a gentle N 2 gas stream (at 60°C) and redissolved in methanol. The sample solution was injected into the column (Nova-Pack C18, Waters) and detected at 210 nm. Elution was carried out at 40°C with methanol as the mobile phase at a flow rate of 1.0 ml/min.
Statistical Analysis Data were compared using analysis of variance and Student's t-test. A p value of 0.05 or 0.01 was considered significant.
RESULTS AND DISCUSSION

Effects of AF on the Association of SG-Liposomes with
HepG2 Cells On accumulation of drug entrapped in SG-liposomes to the liver, we used DiI as a lipophilic fluorescent marker for lipid layers of liposomes to clarify the interaction of SG-liposomes with HepG2 cells. Figure 2 shows the association of SG-(a) and non-SG-liposomes (b) with HepG2 cells incubated for 1 h at 4°C or 37°C. SG-liposomes showed significantly higher association with the cells at 37°C than at 4°C (pϽ0.01) unlike non-SG-liposomes. ASGP-R on hepatocytes recognizes galactose residues and mediates their uptake by endocytosis. AF, which is a glycoprotein having galactose residues, competes with galactose residues for the specific recognition by ASGP-R and thereby inhibits ASGP-R-mediated endocytosis. 17, 18) The inhibition of the association by AF indicates the involvement of galactose-modified carriers such as liposomes modified with AF 19) or galactosylated lipid 20) with ASGP-R-mediated endocytosis. The association of SG-liposomes was significantly reduced by addition of 1 mg/ml AF (pϽ0.05), unlike non-SGliposomes. Binding to the cell surface occurred at 4°C but internalization did not. These findings suggested that SGliposomes not only bound but were also internalized into HepG2 cells at 37°C, and that a portion of the SG-liposomes were taken up by the cells via ASGP-R or at least via an AFsensitive pathway.
Affinity of Sit-G with HepG2 Cells
The affinity of SGliposomes to HepG2 cells may imply other interactions. We could not divide ASGP-R mediated endocytosis and penetration-enhancing effect of SG-liposomes since they occurred only at 37°C. Therefore, we assessed the interaction between Sit-G and HepG2 cells in real time using the IAsys cuvettebased resonant mirror system. The adsorption of material onto the horizontal sensor surface is followed by resonance angle shifts, provided the adsorbed material has a refractive index different from that of the bulk solution. The biosensor measures changes in resonant angle that occur on binding of HepG2 or HeLa cells to Sit-G immobilized on a cuvette surface in real time. Figure 3 shows sequential binding of the cells with Sit-G when the cells were cumulatively added to the cuvette. Interaction of Sit-G with both cell lines was increased with time and cell concentration, and changes in HepG2 cells were obvious compared to those in HeLa cells. These observations suggested that Sit-G has higher affinity with HepG2 than HeLa cells. This affinity might be one of reasons for accumulation of SG-liposomes in the liver.
Penetration-Enhancing Effect of Sit-G in Hepatocyte SG and Sit-G have been reported to be penetration enhancers and Sit-G was a more effective enhancer than SG.
9,10) When SG-liposomes accumulated in the liver, the concentration of Sit-G might be the level leading penetration-enhancing effect close to hepatocytes. To estimate the penetration-enhancing effect of Sit-G in hepatocytes, 5 mg/ml FD-4 solution was incubated with HepG2 cells in the presence of 100 mM oleic acid or Sit-G for 1 h at 4°C or 37°C as shown in Fig. 4 . FD-4 is one of suitable model drug to see the penetration-enhancing effect. The FD-4 solution used in these experiments contained 1% DMSO to disperse these enhancers uniformly because of their fairly low solubility in water. Oleic acid was used as an active control as it is often used as a penetration enhancer by increasing the motional freedom or fluidity of membrane phospholipids, 21) and is capable of nonspecific disruption of the alveolar membrane at high concentrations (0.1 mM). 21, 22) The association of FD-4 was not enhanced by 100 mM oleic acid at 37°C, showing the same value as at 4°C and control (FD-4 solution containing 1% DMSO), but Sit-G (100 mM) significantly increased it at 37°C as compared that with at 4°C. These findings suggested that Sit-G increased the association of FD-4 with HepG2 cells at 37°C.
Effects of Sit-G concentration on the association of both FD-4 (a) and Sit-G (b) incubated with 5 mg/ml FD-4 solution were examined for 1 h with HepG2 cells (Fig. 5) . The levels of association of FD-4 and Sit-G at 37°C were increased with increases in Sit-G concentration and positive correlations were found between the amounts of FD-4 and Sit-G (rϭ0.964 between association of FD-4 and Sit-G).
The effects of incubation time on the association of FD-4 The effects of incubation time and Sit-G concentration on the association % of FD-4 and Sit-G are summarized in Table 1 . The association % of Sit-G was approximately 10% of that added after 60 min incubation regardless of Sit-G concentration added, suggesting partitioning of Sit-G into the cell membrane. These results suggested that Sit-G increases the association of FD-4 by means of distribution of Sit-G into the cell membrane. Following application of FD-4 powder containing Sit-G (FD-4/Sit-Gϭ1/2, w/w) to excised rabbit nasal mucosa for 30 min in vitro, incorporation of 3.3% Sit-G into the nasal mucosa increased FD-4 permeability by approximately 1.8-fold compared to the control. 23) These findings confirmed that Sit-G is a mucosal penetration enhancer 9, 10) and enhances the permeability by increasing the fluidity of phospholipid membranes. 10) Taking these observations into consideration, particles smaller than 100 nm may be able to leave the circulation through fenestrations to be taken up by hepatocytes. However, a portion of the injected liposomes will end up in the Kupffer cells rather than the hepatocytes. Soma et al. 24) reported that macrophages act as a reservoir of drug after phagocytosis of DXR-loaded nanoparticles. Therefore larger SG-liposomes might be stored in macrophages after uptake and the released Sit-G from the Kupffer cells might interact with hepatocytes as a penetration enhancer to increase drug uptake.
In conclusion, the association of SG-liposomes with the liver in vivo may be related to recognition of glucose residues of SG by ASGP-R and to the high affinity and penetration- enhancing effect of Sit-G in hepatocytes. As a result of these combined processes, injected SG-liposomes might be effectively accumulated to the hepatocytes. These findings suggested that SG and Sit-G incorporated into liposomes are effective targeting carriers of drugs for hepatocytes.
